Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use QUILLICHEW ER ® safely and effectively. See full prescribing information for QUILLICHEW ER ® . QUILLICHEW ER ® (methylphenidate hydrochloride) extended-release chewable tablets , for oral use, CII Initial U.S. Approval: 1955
Medication labelWhy this: Advisory · dailymed-prescription
QuilliChew ER is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) [see Clinical Studies ( 14 ) ]. Limitations of Use The use of QuilliChew ER is not recommended in pediatric patients younger than 6 years of age because they had higher plasma exposure and a higher incidence of adverse reactions (e.g., weight loss) than patients 6 years and older at the same dosage [see Warnings and Precautions ( 5.7 ) , Use in Specific Populations ( 8.4 ) ].
- generic_name
- methylphenidate hydrochloride
- product_names
- methylphenidate hydrochloride
- ndc
- 24478-074, 24478-074-01, 24478-074-02, 24478-075, 24478-075-01, 24478-075-02, 24478-076, 24478-076-01, 24478-076-02
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en